Hopefully we get news on final results of burns trial. They did say final data early 2022. If they can identify path through to phase 3 and eventually to market and income generation that could bring a big lift. The potential here is huge. A spray on anti biotic that works against all bacteria with no side effects and no resistance build up. I'd love to see a clear path for the product to get to market as I think that is still a bit of an unknown. If the results remain as good as initial ones were then surely pressure would start to build on the company to get a product out. I'm hoping the burns hospital doing current trial will want to keep using it.
RCE Price at posting:
96.5¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)